Cationic host defence peptides as a novel treatment for respiratory viral infections

D. Davidson (Edinburgh (Edinburgh), United Kingdom)

Source: International Congress 2018 – Antimicrobial host defence and innate immunity in the lung
Session: Antimicrobial host defence and innate immunity in the lung
Session type: Symposium
Number: 5167
Disease area: Respiratory infections

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Davidson (Edinburgh (Edinburgh), United Kingdom). Cationic host defence peptides as a novel treatment for respiratory viral infections. International Congress 2018 – Antimicrobial host defence and innate immunity in the lung

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The innate defence peptide BPIFA1/SPLUNC1 restricts respiratory viral infections
Source: International Congress 2019 – Infections, the microbiome and host defence peptides in the development and progression of asthma
Year: 2019


Innate immunity in the lung: how epithelial cells fight against respiratory pathogens
Source: Eur Respir J 2004; 23: 327-333
Year: 2004



Improving the innate immune response in respiratory infections: the use of repurposed drugs
Source: Virtual Congress 2020 – Antibiotic resistance: the way forward
Year: 2020


Interaction of antibacterial agents with host respiratory defences
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=45
Year: 2004

The role of viral and bacterial infections in asthma severity
Source: Annual Congress 2005 - PG3 - Asthma: natural history, risk factors and overall management
Year: 2005

Dynamics of IFN-ß responses during respiratory viral infection: insights for therapeutic strategies
Source: International Congress 2019 – Mechanisms underlying respiratory infection
Year: 2019


A novel immune biomarker IFI27 discriminates between influenza and bacteria in patients with suspected respiratory infection
Source: Eur Respir J, 49 (6) 1602098; 10.1183/13993003.02098-2016
Year: 2017



Pathomechanisms mediating bacterial co-infection following respiratory viral disease
Source: Lung Science Conference 2015
Year: 2015




A novel immune regulatory function of neutrophils in rhinovirus infections
Source: Lung Science Conference 2015
Year: 2015




Validation of an in vitro tracheal model for the study of innate host defence mechanism in respiratory tract infections
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014


How infections can modify lung immunity
Source: Guideline 2001
Year: 2001

How infections can modify lung immunity
Source: Eur Respir J 2001; 18: 442-443
Year: 2001


An innate defence role for BPIFA1/SPLUNC1 against influenza-A virus infection
Source: International Congress 2015 – The multiple faces of host defense
Year: 2015


Some aspects of mucosal immune response in children with bacterial upper respiratory tract infections
Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans
Year: 2019


Viruses in asthma and COPD: mechanisms and defence
Source: Annual Congress 2005 - Microorganisms: good, bad or ugly in allergic respiratory disease
Year: 2005